Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 70.15%
March 31, 2026 70.56%
December 31, 2025 71.37%
September 30, 2025 77.30%
June 30, 2025 64.24%
March 31, 2025 61.66%
December 31, 2024 57.04%
September 30, 2024 58.81%
June 30, 2024 48.83%
March 31, 2024 50.35%
December 31, 2023 45.38%
September 30, 2023 33.78%
June 30, 2023 51.84%
March 31, 2023 35.97%
December 31, 2022 60.37%
September 30, 2022 57.58%
Date Value
June 30, 2022 57.82%
March 31, 2022 52.75%
December 31, 2021 49.37%
September 30, 2021 54.02%
June 30, 2021 64.50%
March 31, 2021 67.06%
December 31, 2020 71.60%
September 30, 2020 68.83%
June 30, 2020 63.96%
March 31, 2020 64.62%
December 31, 2019 66.85%
September 30, 2019 71.73%
June 30, 2019 68.00%
March 31, 2019 51.55%
June 30, 2018 48.89%
March 31, 2018 50.16%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Personalis, Inc. 21.21%
10X Genomics, Inc. 74.36%
Alamar Biosciences, Inc. (California) 60.21%
Champions Oncology, Inc. 48.48%
Medpace Holdings, Inc. 27.56%

Gross Profit Margin (Quarterly) Related Metrics